Jazz Pharmaceuticals (JAZZ) Change in Taxes (2012 - 2026)

Jazz Pharmaceuticals' Change in Taxes history runs 15 years deep, the most recent figure standing at $37.4 million for Q1 2026.

• On a quarterly basis, Change in Taxes rose 187.69% year-over-year to $37.4 million in Q1 2026; TTM through Mar 2026 was $61.6 million, a 471.23% increase from a year earlier, with the FY2025 full-year figure at $37.2 million, up 352.5% from the prior year.
• Change in Taxes climbed to $37.4 million in Q1 2026 per JAZZ's latest filing, from -$34.8 million in the prior quarter.
• Across five years, Change in Taxes topped out at $46.3 million in Q2 2025 and bottomed at -$35.9 million in Q4 2023.
• The 5-year median for Change in Taxes is $12.7 million (2025), against an average of $4.9 million.
• Across the five-year window, Change in Taxes tumbled 2264.41% in 2023 and soared 1358.7% in 2025, its largest moves.
• Year by year, Change in Taxes stood at -$1.5 million in 2022, then tumbled by 2264.41% to -$35.9 million in 2023, then grew by 3.06% to -$34.8 million in 2024, then climbed by 0.16% to -$34.8 million in 2025, then jumped by 207.52% to $37.4 million in 2026.
• Per Business Quant, the three latest JAZZ Change in Taxes figures stand at $37.4 million (Q1 2026), -$34.8 million (Q4 2025), and $12.7 million (Q3 2025).